VIVUS (VVUS), Arena (ARNA) Tick Higher on Positive Orexigen (OREX) News
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Join SI Premium – FREE
VIVUS (Nasdaq: VVUS) and Arena Pharma (Nasdaq: ARNA) shares are ticking higher Wednesday morning following positive news from peer Orexigen (Nasdaq: OREX).
Earlier, Orexigen said enrollment in its Light Study was moving along faster than anticipated. The pharma now expects to close enrollment to new patients in the fourth quarter of 2012.
The time frame compares with a July 11th release, in which Orexigen also noted the velocity of enrollment and said completion would be in the first-quarter of 2013.
Shares of VIVUS are up about 0.8 percent while Arena is about 0.2 percent better ahead of U.S. markets opening.
Earlier, Orexigen said enrollment in its Light Study was moving along faster than anticipated. The pharma now expects to close enrollment to new patients in the fourth quarter of 2012.
The time frame compares with a July 11th release, in which Orexigen also noted the velocity of enrollment and said completion would be in the first-quarter of 2013.
Shares of VIVUS are up about 0.8 percent while Arena is about 0.2 percent better ahead of U.S. markets opening.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- Samsung Plans As Much As $79 Billion In Shareholder Returns - Bloomberg
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
